Skip to main content
Donate
Login
IASLC's 50th Anniversary
IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
About Us
About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Careers
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Publications, Resources & Guidelines
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Lung Cancer 360
Research Projects
Research Projects
Staging Project
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Early-Career Opportunities
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
Partner Society Membership Offers
Patient Advocacy
Patient Advocacy
STARS
Advocacy Partner Spotlight
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 1 - 12 items out of 91 results
ILCN article
The New WHO Classification of Lung Tumors
ILCN article
Lung Cancer Biomarker Testing Patterns Varied Widely in Japan
ILCN article
Spine Stereotactic Radiosurgery: A Critical Evaluation of the Evidence to Guide Clinical Practice
ILCN article
Radiotherapy Inaccessibility in Lung Cancer Care: An Ongoing Crisis
ILCN article
Cardiac Toxicity of Lung Cancer Radiotherapy
ILCN article
Hippocampal-Sparing Brain Irradiation: The Future of Brain Metastases Treatment and Prevention?
ILCN article
Prophylactic Radiotherapy: A Case for Patients at High Risk of Brain Metastases
ILCN article
The Role of PORT in Patients With Completely Resected Stage III-N2 NSCLC: A Pro/Con - The Con Side
ILCN article
The Role of PORT in Patients With Completely Resected Stage III-N2 NSCLC: A Pro/Con - The Pro Side
ILCN article
Deeper Dive Toxicity of Lung SBRT and Concurrent Immunotherapy Combinations: What We Know and What We Still Need to Learn
ILCN article
The Dandelion Dilemma of Brain Metastases: Treating the Whole Lawn or the Weeds Separately
ILCN article
PET vs. CT in Lung Cancer Surveillance: The ‘Pro’ Side from the Nuclear Medicine Perspective
Pagination
1
2
3
4
5
6
7
8
›
Next page
Last
Last page